Brilliant Deception? Our thoughts on the controversial Allē article.

5 September 2024

We’ve had a ton of messages from clients today regarding this article.

Allergan’s Hidden Agenda: The Critical Risks of Allē Every Aesthetic Provider Should Know.


It has gone viral in our space!

So what are our thoughts?

We believe Allē is a game-changer for patient acquisition, no doubt about it.

It's great for building loyalty with Allergan products like Botox and Juvéderm, but here’s the thing: relying solely on Allē might limit your practice's flexibility and profits.

But Allē owns your patients - not you.
It’s Allē's loyalty program - not yours. 
Which is a risk.

If you’re a RepeatMD client you can have the best of both worlds. 

Here's why:

  • Allē = Acquisition. It’s valuable for attracting and retaining patients, but it ties you to Allergan's products.

  • RepeatMD = Retention (and Flexibility.) Rewards your patients for all purchases. Offer financing for all treatments—boosting revenue, increasing patient access, and giving you more control over your practice.

    And most importantly you OWN your customer, not Allergan!
    That way you can market your products and services with total freedom

By combining RepeatMD and Allē, you get:

  • Allē’s patient acquisition power plus RepeatMD’s full-service flexibility. More treatments, more profit, more freedom!


Those are our thoughts!

Not a RepeatMD customer yet? Let’s schedule a strategy call to discuss if you're a fit.

Schedule Here